A new approach to the development of assessment guidelines for osteoporosis

J. A. Kanis, D. Black, C. Cooper, P. Dargent, B. Dawson-Hughes, C. De Laet, P. Delmas, J. Eisman, O. Johnell, B. Jonsson, L. Melton, A. Oden, S. Papapoulos, H. Pols, R. Rizzoli, A. Silman, A. Tenenhouse

Research output: Contribution to journalArticle

242 Citations (Scopus)

Abstract

The diagnosis of osteoporosis is made from the measurement of BMD. DXA at the hip is the appropriate diagnostic site. Current clinical guidelines follow the principle that BMD measurements are indicated in individuals with risk factors for fracture and that treatment is recommended in those with a BMD below a critical value. In some countries reimbursement for the costs of treatment depend upon such thresholds for BMD. In Europe the critical value corresponds to a T-score of-2.5 SD, whereas in the USA less stringent criteria are used. It is evident, however, that fracture risk at any given T-score varies markedly according to age and other risk factors. This has led to the view that interventions should be targeted to those at high risk, irrespective of a fixed BMD threshold. In this sense, BMD is utlized as a risk assessment, since in many instances intervention thresholds will be less stringent than the diagnostic threshold. Thus, intervention thresholds need to differ from diagnostic thresholds and be based on fracture probabilities. A 10-year fracture probability appears to be an appropriate time frame. There are a number of problems to be overcome in the development of assessment guidelines. They need to take account of not only the risk of hip fracture but also that of other fractures which contribute significantly to morbidity, particularly in younger individuals. A promising approach is to weight fracture probabilities according to the disutility incurred compared with hip fracture probability. Account also needs to be taken of the large geographic variation in fracture probabilities worldwide. A further challenge for the future will be to identify risk factors that predict fracture with high validity in different regions of the world and their independent contributions, so that models of risk prediction can be constructed and ultimately validated in independent cohorts.

Original languageEnglish (US)
Pages (from-to)527-536
Number of pages10
JournalOsteoporosis International
Volume13
Issue number7
DOIs
StatePublished - 2002

Fingerprint

Osteoporosis
Guidelines
Hip Fractures
Health Care Costs
Hip
Morbidity
Weights and Measures

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kanis, J. A., Black, D., Cooper, C., Dargent, P., Dawson-Hughes, B., De Laet, C., ... Tenenhouse, A. (2002). A new approach to the development of assessment guidelines for osteoporosis. Osteoporosis International, 13(7), 527-536. https://doi.org/10.1007/s001980200069

A new approach to the development of assessment guidelines for osteoporosis. / Kanis, J. A.; Black, D.; Cooper, C.; Dargent, P.; Dawson-Hughes, B.; De Laet, C.; Delmas, P.; Eisman, J.; Johnell, O.; Jonsson, B.; Melton, L.; Oden, A.; Papapoulos, S.; Pols, H.; Rizzoli, R.; Silman, A.; Tenenhouse, A.

In: Osteoporosis International, Vol. 13, No. 7, 2002, p. 527-536.

Research output: Contribution to journalArticle

Kanis, JA, Black, D, Cooper, C, Dargent, P, Dawson-Hughes, B, De Laet, C, Delmas, P, Eisman, J, Johnell, O, Jonsson, B, Melton, L, Oden, A, Papapoulos, S, Pols, H, Rizzoli, R, Silman, A & Tenenhouse, A 2002, 'A new approach to the development of assessment guidelines for osteoporosis', Osteoporosis International, vol. 13, no. 7, pp. 527-536. https://doi.org/10.1007/s001980200069
Kanis JA, Black D, Cooper C, Dargent P, Dawson-Hughes B, De Laet C et al. A new approach to the development of assessment guidelines for osteoporosis. Osteoporosis International. 2002;13(7):527-536. https://doi.org/10.1007/s001980200069
Kanis, J. A. ; Black, D. ; Cooper, C. ; Dargent, P. ; Dawson-Hughes, B. ; De Laet, C. ; Delmas, P. ; Eisman, J. ; Johnell, O. ; Jonsson, B. ; Melton, L. ; Oden, A. ; Papapoulos, S. ; Pols, H. ; Rizzoli, R. ; Silman, A. ; Tenenhouse, A. / A new approach to the development of assessment guidelines for osteoporosis. In: Osteoporosis International. 2002 ; Vol. 13, No. 7. pp. 527-536.
@article{63b1e3d24d2e4194a445bfb42de223b8,
title = "A new approach to the development of assessment guidelines for osteoporosis",
abstract = "The diagnosis of osteoporosis is made from the measurement of BMD. DXA at the hip is the appropriate diagnostic site. Current clinical guidelines follow the principle that BMD measurements are indicated in individuals with risk factors for fracture and that treatment is recommended in those with a BMD below a critical value. In some countries reimbursement for the costs of treatment depend upon such thresholds for BMD. In Europe the critical value corresponds to a T-score of-2.5 SD, whereas in the USA less stringent criteria are used. It is evident, however, that fracture risk at any given T-score varies markedly according to age and other risk factors. This has led to the view that interventions should be targeted to those at high risk, irrespective of a fixed BMD threshold. In this sense, BMD is utlized as a risk assessment, since in many instances intervention thresholds will be less stringent than the diagnostic threshold. Thus, intervention thresholds need to differ from diagnostic thresholds and be based on fracture probabilities. A 10-year fracture probability appears to be an appropriate time frame. There are a number of problems to be overcome in the development of assessment guidelines. They need to take account of not only the risk of hip fracture but also that of other fractures which contribute significantly to morbidity, particularly in younger individuals. A promising approach is to weight fracture probabilities according to the disutility incurred compared with hip fracture probability. Account also needs to be taken of the large geographic variation in fracture probabilities worldwide. A further challenge for the future will be to identify risk factors that predict fracture with high validity in different regions of the world and their independent contributions, so that models of risk prediction can be constructed and ultimately validated in independent cohorts.",
author = "Kanis, {J. A.} and D. Black and C. Cooper and P. Dargent and B. Dawson-Hughes and {De Laet}, C. and P. Delmas and J. Eisman and O. Johnell and B. Jonsson and L. Melton and A. Oden and S. Papapoulos and H. Pols and R. Rizzoli and A. Silman and A. Tenenhouse",
year = "2002",
doi = "10.1007/s001980200069",
language = "English (US)",
volume = "13",
pages = "527--536",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "Springer London",
number = "7",

}

TY - JOUR

T1 - A new approach to the development of assessment guidelines for osteoporosis

AU - Kanis, J. A.

AU - Black, D.

AU - Cooper, C.

AU - Dargent, P.

AU - Dawson-Hughes, B.

AU - De Laet, C.

AU - Delmas, P.

AU - Eisman, J.

AU - Johnell, O.

AU - Jonsson, B.

AU - Melton, L.

AU - Oden, A.

AU - Papapoulos, S.

AU - Pols, H.

AU - Rizzoli, R.

AU - Silman, A.

AU - Tenenhouse, A.

PY - 2002

Y1 - 2002

N2 - The diagnosis of osteoporosis is made from the measurement of BMD. DXA at the hip is the appropriate diagnostic site. Current clinical guidelines follow the principle that BMD measurements are indicated in individuals with risk factors for fracture and that treatment is recommended in those with a BMD below a critical value. In some countries reimbursement for the costs of treatment depend upon such thresholds for BMD. In Europe the critical value corresponds to a T-score of-2.5 SD, whereas in the USA less stringent criteria are used. It is evident, however, that fracture risk at any given T-score varies markedly according to age and other risk factors. This has led to the view that interventions should be targeted to those at high risk, irrespective of a fixed BMD threshold. In this sense, BMD is utlized as a risk assessment, since in many instances intervention thresholds will be less stringent than the diagnostic threshold. Thus, intervention thresholds need to differ from diagnostic thresholds and be based on fracture probabilities. A 10-year fracture probability appears to be an appropriate time frame. There are a number of problems to be overcome in the development of assessment guidelines. They need to take account of not only the risk of hip fracture but also that of other fractures which contribute significantly to morbidity, particularly in younger individuals. A promising approach is to weight fracture probabilities according to the disutility incurred compared with hip fracture probability. Account also needs to be taken of the large geographic variation in fracture probabilities worldwide. A further challenge for the future will be to identify risk factors that predict fracture with high validity in different regions of the world and their independent contributions, so that models of risk prediction can be constructed and ultimately validated in independent cohorts.

AB - The diagnosis of osteoporosis is made from the measurement of BMD. DXA at the hip is the appropriate diagnostic site. Current clinical guidelines follow the principle that BMD measurements are indicated in individuals with risk factors for fracture and that treatment is recommended in those with a BMD below a critical value. In some countries reimbursement for the costs of treatment depend upon such thresholds for BMD. In Europe the critical value corresponds to a T-score of-2.5 SD, whereas in the USA less stringent criteria are used. It is evident, however, that fracture risk at any given T-score varies markedly according to age and other risk factors. This has led to the view that interventions should be targeted to those at high risk, irrespective of a fixed BMD threshold. In this sense, BMD is utlized as a risk assessment, since in many instances intervention thresholds will be less stringent than the diagnostic threshold. Thus, intervention thresholds need to differ from diagnostic thresholds and be based on fracture probabilities. A 10-year fracture probability appears to be an appropriate time frame. There are a number of problems to be overcome in the development of assessment guidelines. They need to take account of not only the risk of hip fracture but also that of other fractures which contribute significantly to morbidity, particularly in younger individuals. A promising approach is to weight fracture probabilities according to the disutility incurred compared with hip fracture probability. Account also needs to be taken of the large geographic variation in fracture probabilities worldwide. A further challenge for the future will be to identify risk factors that predict fracture with high validity in different regions of the world and their independent contributions, so that models of risk prediction can be constructed and ultimately validated in independent cohorts.

UR - http://www.scopus.com/inward/record.url?scp=0036068520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036068520&partnerID=8YFLogxK

U2 - 10.1007/s001980200069

DO - 10.1007/s001980200069

M3 - Article

C2 - 12111012

AN - SCOPUS:0036068520

VL - 13

SP - 527

EP - 536

JO - Osteoporosis International

JF - Osteoporosis International

SN - 0937-941X

IS - 7

ER -